New Drug Effective For Prostate Cancer Being Tried In Breast Cancer
 

Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer

http://www.drugs.com/clinical_trials...owth-3920.html